Literature DB >> 6470125

Kingella kingae osteomyelitis of the clavicle.

H A Rotbart, W M Gelfand, M P Glode.   

Abstract

Kingella kingae is the most recent addition to the list of etiologic agents causing osteomyelitis and septic arthritis in previously well children. A case is presented of a child with K. kingae osteomyelitis of the clavicle--an uncommon site of infection due to any organism. In the hope of facilitating the detection and treatment of this increasingly recognized pathogen, a brief discussion of its microbiologic characteristics and a summary of the patients reported to date with bone and joint infections due to this organism are included. To our knowledge, this is the first discussion of K. kingae in the orthopedic literature.

Entities:  

Mesh:

Year:  1984        PMID: 6470125     DOI: 10.1097/01241398-198408000-00025

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  5 in total

Review 1.  Kingella kingae: carriage, transmission, and disease.

Authors:  Pablo Yagupsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 2.  Kingella kingae intervertebral disk infection.

Authors:  J Amir; P G Shockelford
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

Review 3.  Osteoarticular infections due to Kingella kingae in children.

Authors:  M Lacour; M Duarte; A Beutler; R Auckenthaler; S Suter
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

4.  Kingella kingae: osteoarticular infections of the sternum in children: a report of six cases.

Authors:  Matthias Luegmair; Mourad Chaker; Christine Ploton; Jérôme Berard
Journal:  J Child Orthop       Date:  2008-11-18       Impact factor: 1.548

Review 5.  Similarities and Differences between Clavicular Bacterial Osteomyelitis and Nonbacterial Osteitis: Comparisons of 327 Reported Cases.

Authors:  Nan Jiang; Ping Zhang; Wei-Ran Hu; Zi-Long Yao; Bin Yu
Journal:  J Immunol Res       Date:  2021-01-26       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.